The EU Industrial R&D Investment Scoreboard from the European Commission's Joint Research Centre (JRC) provides economic and financial data and analysis of the top 1,500 corporate R&D investors worldwide. The 2012 Scoreboard reveals that R&D investment is up from 2011 and that R&D investment by EU companies beats the global average. It is on par with US firms, and is far ahead of Japanese companies.
Total R&D investment increased from € 456 bn in 2010 to € 511 bn in 2011. Chinese and Japanese investment showed the largest increases by 1.0 and 0.2 percentage points, respectively.
The top ten companies each invested more than € 5 bn in R&D. They account for 13.5 % of the total R&D investment by the top 1,500 companies – a similar proportion to 2010.
Chemical companies' R&D investment remained similar to 2010.
Firms within the Pharmaceutical and Biotechnology sector showed the highest average sales growth (23.7 %).
 The 2012 EU Industrial R&D Investment Scoreboard, European Commission's Joint Research Centre (JRC), Brussels, Belgium.
 Facts and Figures 2012, European Chemical Industry Council (Cefic), Brussels, Belgium.
 Top 100 Chemical Companies, ICIS Chemical Business Magazine, 2012, September.
 Annual Pharma Exec 50, J. Cacciotti, P. Clinton, Pharmaceutical Executive, 2012, May.
Also of interest:
Article Views: 3164